Denied
Your plan said no. That is not the end of it.
Before you pay cash, work the appeal. It is free, the deadlines are short, and an independent reviewer can overrule your plan.
First: which plan denied you?
The route, the deadline and the words you need are different for each. Start on your own plan's page.
Second: file, before the clock runs out
Nearly everyone who loses an appeal loses it on a deadline rather than on the merits. Here are the outer limits for the four routes below — which one applies depends on the plan that denied you, picked above.
Sources read August 2026; Medicare Part D — redetermination: October 2026.
Each figure is the outer filing limit, not a guarantee — a plan or a state notice can set a shorter one where the rules permit it. Read your notice and contact the plan promptly if its instructions conflict with the published rule.
- Your plan said no. What now?The deadlines and steps for appealing a commercial or employer plan denial of a GLP-1, including external review by an independent body.
- How to ask Part D for an exceptionHow to request a formulary exception or get a step therapy or prior authorization requirement waived under Medicare Part D, and the deadlines that apply.
- How to ask for a Medicaid fair hearingHow to request a Medicaid fair hearing after a denial, the federal 90-day ceiling on filing, and why your state's deadline may be shorter.
Two things worth doing before you write anything. Work out your dates from the date printed on your notice, and read what that letter is required to tell you — a notice missing the criterion it decided against is common, and you can demand the rest of it free of charge.
If the letter cites a weight-loss exclusion rather than a missed criterion, read whether you can appeal an employer plan's exclusion. If it says you missed a criterion, compare it with the published Zepbound or Wegovy prior authorization rules. Calling first? Use this phone script.
Third: a fork most people are not told about
Manufacturers run two different things, and the difference decides which one you can use. A copay savings card is barred to anyone on a government program. A self-pay program is not the same thing, and being on a government plan does not disqualify you from paying that price.
Read August 2026
Manufacturer copay savings cards exclude anyone enrolled in a government program. Lilly's Zepbound card requires that you are "not enrolled in any state, federal, or government funded healthcare program," naming Medicaid, Medicare, Medigap, DoD, VA and TRICARE.
Eli Lilly and Company · source
A self-pay program is a different thing. Novo Nordisk states that patients enrolled in government, state or federally funded programs are able to pay the self-pay price for their prescription.
Novo Nordisk · source
If you hold both commercial and government coverage, Novo counts you as government-insured for the savings offer. Federal Employees Health Benefits, Affordable Care Act exchange plans and state employee plans are explicitly not government programs for this purpose.
Novo Nordisk · source
Coupons and discount programs may not be applied to Medicare GLP-1 Bridge claims, so the $50 Bridge copay does not stack with manufacturer help.
Centers for Medicare & Medicaid Services, effective August 2026 · source
Read September 2026
Lilly's separate self-pay KwikPen card "is for self‑paying (cash) patients only": you agree not to seek reimbursement "from any third‑party payer, including private insurance or state or federal healthcare programs, nor apply those costs toward any deductible or true out‑of‑pocket requirements." Its eligibility list is residency in the United States or Puerto Rico and age 18 or older, with no government-program exclusion, and Lilly's savings page offers it under the Medicare, "Government (other)" and "No insurance" choices.
Eli Lilly and Company, Zepbound self-pay KwikPen terms and conditions, effective August 2026 · source · savings page
So a government plan shuts you out of the copay card, not out of the maker's cash price. Lilly's self-pay KwikPen card has no government-program exclusion, but paying cash means the money can't count toward a deductible. For the full rules, prices and the reasons a card gets rejected, see how the Zepbound savings card works and where brand Zepbound is cheapest without insurance.
If you are on Medicare, check the Bridge first
A CMS demonstration is covering some GLP-1s at a $50 monthly copay from July 2026 through December 2027, on a prescriber attestation. It is not part of the normal Part D benefit and most coverage explainers do not mention it. What it requires.
If the appeal fails, or you cannot wait
Cash-pay telehealth is the fallback, not the bargain: you pay the whole cost yourself, and a covered prescription is almost always cheaper than any of these. Use this route when coverage has actually been exhausted, or when you need to start while an appeal runs.
These companies pay us a commission if you start care through the links below. That is how this site is funded, and it does not change what is written above. How we pay for this.
| Company | What we found on its own site |
|---|---|
| PartnerStrut HealthCheck availability | A telehealth storefront where weight loss is one of six categories. No GLP-1 price is published on the page our link opens. |
| PartnerRxSpan MDCheck availability | Multi-category telehealth that promises transparent pricing, then publishes no GLP-1 price on the page our link opens. |
| PartnerSnagRxCheck availability | Compounded semaglutide at $69 a month and tirzepatide at $119, the same at every dose, with no membership. Both are countdown sale prices, marked down from $299 and $399. Not available in Louisiana. |
| PartnerSkinnyRxCheck availability | Compounded semaglutide and tirzepatide injections at $99 for the first month, tablets at $149 and $199. No second-month price is printed for any of them. |
| PartneryourEraCheck availability | Compounded semaglutide at $79.20 a month and tirzepatide at $159.20. Both are six-month-plan prices, and the plan carries a six-month commitment. |
| PartnerbmiMDCheck availability | Compounded semaglutide from $119 a month and tirzepatide from $179. Both are limited-time sale prices, marked down from $228.60 and $349.20. |
| PartnerCollectiveCheck availability | Compounded semaglutide at $59 a month and tirzepatide at $69 at every dose, plus a required $199 yearly membership. It's free for 21 days, then billed for the full year at once, and it isn't refundable. |
| PartnerSprout HealthCheck availability | Compounded semaglutide from $149 a month and tirzepatide from $199, on plans that renew automatically. Also lists brand Wegovy and Zepbound. |
| PartnerWillowCheck availability | Compounded semaglutide at $299 a month (weekly injection or daily tablet) and tirzepatide injections at $399. HSA and FSA accepted; a full refund applies only if you cancel before the prescription reaches the pharmacy. |
| PartnerHumeCare+Check availability | A self-pay membership with no price shown before checkout, renewing automatically. The home page promises your money back if you don't lose 10 percent in six months; the terms limit that to 90 days, first-time users and no measurable loss. |
| PartnerEnhance MDCheck availability | Offers compounded semaglutide and tirzepatide with provider consultations and follow-up. Compounded drugs are not FDA-approved; ask which pharmacy will dispense your prescription and what continuing care includes. |
| PartnerCoreAge RxCheck availability | Compounded semaglutide advertised at $99 a month at every dose. The page our link opens has shown $149 instead, and a consultation fee can be added that may not be refundable. |
| PartnerOakCheck availability | One flat price at every dose, with shipping and supplies included free. |
| PartnerGala HealthCheck availability | One price at every dose. The advertised rate needs a yearly subscription. |
| PartnerDirect MedsCheck availability | One price at every dose from $147, with no monthly membership. The page states its discount two ways ($150 off in the banner, up to $200 off on the tiles), so check the total at checkout. |
| PartnerFoundCheck availability | Bills clinician visits to your insurance where it's in network, with the drug charged separately. Its Medicare offer, brand GLP-1s from $50 a month, doesn't count toward your Part D deductible or out-of-pocket maximum, and Extra Help doesn't apply. |
| PartnerEdenCheck availability | Semaglutide at $99 a month at every dose, with no membership on the page our link opens. Eden's own site pairs the same $99 with a required membership ($39 the first month, then $99), so check which one you're signing up for. |
| PartnerShedRxCheck availability | Injections plus needle-free drops and lozenges. You see a price only after the questionnaire, and the oral forms aren't sold in sixteen states. |
| PartnerHealthRXCheck availability | Compounded semaglutide at $133 a month on a three-month plan ($99 on twelve), tirzepatide from $209 ($179 on twelve). Its member reviews are labeled illustrative composites, not real patients. |
| PartnerMEDGmCheck availability | GLP-1 injections from $179 and tablets from $249. Brand options are a membership plus the drug's own cost: $99 for Zepbound or Wegovy, $171 for Ozempic. It discloses AI content and actor imagery. |
| PartnerBodybuilding Health+Check availability | Compounded tirzepatide at $174.67 to $209 a month, lower the more months you buy at once; semaglutide is tiered the same way. Operated by Dynamo Group LLC. |
Prices in those notes were read from each company's own site in September 2026, October 2026 and August 2026, and they change often. Check the current number before you buy.
Where this comes from
Read August 2026 unless marked.
- Eli Lilly and Company — Open the document
- Novo Nordisk — Open the document
- Eli Lilly and Company, Zepbound self-pay KwikPen terms and conditions, effective August 2026 — Open the document (read September 2026)
- Centers for Medicare & Medicaid Services, effective August 2026 — www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-
Nothing here is medical or legal advice. Deadlines and coverage rules change; every fact on this site carries the date it was read and a link to its source.